Readers may recall a recent post on a study purporting to show that one of the best insurance policies against a retraction is to employ a medical writer. Well, a group of Iranian surgeons did just that. How’d it work out for them?
Of course, since you’re reading about this on Retraction Watch, you already know the answer to that one, don’t you?
The World Journal of Surgery has retracted a 2010 article written by hired guns who apparently decided to perform wordthievery rather than wordsmithery.
If a paper that has never been cited is retracted, will it be missed?
Japanese researchers have retracted an obscure 1996 article in an equally obscure physics journal after concluding — some 15 years later — that their fundamental assertion was mistaken.
The paper, “Uptake and excretion of cobalt in the crustacean Portunus trituberculatus,” in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, purported to show that a form of the element cobalt might be helpful in tracing the growth of Portunus trituberculatus, otherwise known as the blue crab.
That’s the world’s most harvested crab species and a particular favorite in Asia. But don’t confuse it with the Chesapeake Bay blue crab, Callinectes sapidus, of William Warner’s Pulitzer Prize-winning book, Beautiful Swimmers.
The problem with such elemental tracers, it seems, is that crabs moult repeatedly, shedding their shells, along with the elements that build up inside them. According to researchers from the Research Institute for Advanced Science and Technology and the Osaka Prefectural Fisheries Experimental Station, however, a volatile form of cobalt, previously undetected, could be a suitable element for tracing the growth of both crabs and prawns — another important aquaculture species in Asia — over time.
have recently discovered that the cell lines used in their paper were inadvertently misidentified. The cell lines utilized in the paper have now been found to contain the bcr/abl translocation and most likely represent the K562 CML cell line, instead of MMS1 and RPM1 myeloma cell lines. Due to this issue, the relevance of the findings to myeloma and thus, the conclusions of the paper, are not supported by the data. The authors apologize to the readers, reviewers, and editors of Blood for publishing these erroneous data.
That seems straightforward enough, and we couldn’t find any evidence that this problem affected other publications.
The British Journal of Ophthalmology has retracted a 2006 paper which purported to show a link between drugs for erectile dysfunction and a rare form of sudden vision loss called non-arteritic anterior ischaemic optic neuropathy, more commonly known as “Viagra blindness.”
That wouldn’t be terribly interesting, except for this: One of the authors of the paper, a researcher at the University of Alabama named Gerald McGwin Jr., told us that the journal retracted the article because it had become a tool in a lawsuit involving Pfizer, which makes Viagra, and, presumably, men who’d developed blindness after taking the drug:
The article just became too much of a pain in the rear end. It became one of those things where we couldn’t provide all the relevant documentation [to the university, which had to provide records for attorneys]
Ultimately, however, McGwin said that the BJO pulled the plug on the paper.
It was really the journal’s decision to take it out of the literature.
The debate — in entrenched medical circles, anyway — over whether it’s safe to give birth at home can be fierce. Just last month, for example, Naturereported that a review of the subject in the American Journal of Obstetrics & Gynecology that found home births more dangerous than those in the hospital generated so much controversy that it forced an investigation. Outside reviewers found problems, but the journal didn’t think they rose to the level of a retraction. Critics disagreed.
The same fraught subject came up in a paper published in Feminism & Psychology last year by Mary Horton-Salway and Abigail Locke. The original paper had concluded:
Our analysis suggests that the normativity of medical interventions in labour and childbirth is discursively reproduced in ante-natal classes whilst parental choice is limited by a powerful ‘rhetoric of risk’.
An investigation by Emory University in Atlanta has led to the retractions of three articles containing falsified data, but the ambiguous wording of the notices leaves us wondering if they are implying more than they state.
Two of the papers appeared in the journal Arteriosclerosis, Thrombosis, and Vascular Biology. The notices in ATVB implicate a researcher named Lian Zuo, who worked in Emory’s division of cardiology.
Yesterday, we reported that National Geographic had bought ScienceBlogs. We’ve now obtained a recording of a conference call between various members of National Geographic senior management, ScienceBlogs management, and ScienceBloggers — aka Sciblings — that adds some details.
What we’ve learned is that Nat Geo plans to assume control of operations, editorial content, and ad sales by June 1 of this year. And while a post from PZ Myers post said “basically, we’ve been bought,” and we had further confirmation last night of the contents of yesterday’s post from someone familiar with the situation, we want to make sure to point out, high up, that one of the first things that SEED CFO and vice president of finance and operation’s Vera Scavcic said on the call was that SEED would maintain ownership: Continue reading More details emerge on ScienceBlogs-National Geographic deal
This afternoon, PZ Myers, of the wildly popular Pharyngula blog on ScienceBlogs, started a post with a few lines that set science writers on Twitter abuzz:
I have news. Scienceblogs is going to be folded into a new organization sometime soon — basically, we’ve been bought. I can’t discuss all of the details just yet, but let’s just say it is a prestigious national magazine with a healthy bottom line that will do us a lot of good.
Retraction Watch has learned, from a source familiar with the negotiations, that the buyer is National Geographic. We don’t have any details at this point, and Nat Geo has not returned a request for comment [see update at end], but we are confident in reporting this.
There has been some news over the past few weeks about Marc Hauser, the Harvard psychologist found guilty of misconduct by the university last year. First, because Harvard had listed him in a course catalog, The Crimson said that he might be teaching again, following a ban. But that turned out not to be the case, as The Boston Globe reported.
Readers may recall a recent post on a study purporting to show that one of the best insurance policies against a retraction is to employ a medical writer. Well, a group of Iranian surgeons did just that. How’d it work out for them?
